Navigation Links
Ingen Technologies Brings Oxyview(R) to Asia Through Major Medical Distributor
Date:2/12/2008

YUCAIPA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Ingen Technologies, Inc. (OTC Bulletin Board: IGTG), a medical device manufacturer, announced today the signed distribution agreement with Progressive International Holding Co. LTD in Hong Kong to distribute Oxyview(R) in Taiwan, People's Republic of China, Japan and Korea. Please refer to the 8-K filing of this event.

Progressive International Holding Company (PIHK) (http://www.pgiholding.com) and its associate company, Progressive Group Inc (PGI), was founded in 1983 and is one of the major distributors of clinical diagnostic systems, medical devices and point of care products in Taiwan. To pursue the potential business opportunity in China and fully capitalize PGI's sales & marketing experience of more than twenty years, PGI established Progressive International Holding Company (PIHK) in Hong Kong in 2005. PIHK has tremendous synergy by utilizing the experience, expertise and connections of PGI in China and Taiwan to expand its product portfolio in patient oxygen gas flow monitoring devices in the China, Japan and Korea markets.

The distribution agreement calls for a monthly minimum of 10,000 Oxyview(R) units to be purchased by PIHK during a five year period. PIHK has submitted the application to the Chinese government agency known as SFDA for registration of the free sales certificate.

"Ingen looks forward to working closely with Progressive. Julian Yuan, CEO of Progressive, visited our manufacturing facilities last year. Mr. Yuan is CEO of Aviva Biosciences in San Diego, California (http://www.avivabio.com), and has the resources to deliver Oxyview(R) to the Asian markets. Our company is pleased to have the privilege of working with Progressive International Holding Company," stated Scott Sand, Chairman and CEO of Ingen Technologies.

For more information please vis
'/>"/>

SOURCE Ingen Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
2. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
3. Ingen Technologies, Inc. Press Release Retraction
4. Ingenious Med Reports Record Sales and Client Expansions in 2007
5. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
6. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
7. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
8. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
9. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
10. Advanced technologies aim to transform the coaching of top athletes
11. Global Med Technologies(R) Extends Its Worldwide Outreach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)...ake steps to eliminate triggers, experts advise , ...y,re not Scrooges, but people with allergies and a...aditions and need to take special steps to prevent...College of Allergy, Asthma and Immunology (ACAAI)....hoose to decorate with artificial plants, but both...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...Is to Educate Patients and Others about Opportunit...ctal Cancer, ANNAPOLIS, Md., Sept. 4 The Nationa...g and Care announced the appointment of,Randall H....logy Associates, LLC states, "We are pleased to ha...
... --- There,s no magic bullet for wiping out malari...hod that effectively delays the evolution of drug ...lorida researcher says. , David Smith, associate ... current artemisinin-based malaria drugs combined ...
...SAFC Pharma(TM), a focus,area within SAFC(R) ( htt...drich(R) Group (Nasdaq: SIAL ), today officially ...to its Madison (Wisconsin) facility,designed to si...chase of 15 acres of green space in Verona (Wiscon...
...ed Organic and Fair Trade-Certified Drink Featured... Products, NEWTOWN, Pa., Sept. 3 Steaz, the prem...-Certified beverages, has been included on,Women,s...gnizing Steaz, Women,s Health notes consumers can ...
...al, levels triple risk of aggressive disease , ...whose serum calcium levels fall within the high en...to develop fatal prostate cancer, a new report sho...ading too much into the study, given the relativel...
... In July, Christine Demers and Areeba Sadiq ...e and the research coordinator at The Feinstein In...ves but they were going West in search of the seru...q set off for a family reunion in Arkansas. The nu...
Other Medicine News:Health News:National Coalition for Quality Colorectal Cancer Screening and Care Appoints New Executive Director, Randall H. H. Madry: 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 3Health News:SAFC Pharma(TM) Commits to Major Expansion of High Potency API Production at Madison Site 2Health News:SAFC Pharma(TM) Commits to Major Expansion of High Potency API Production at Madison Site 3Health News:Steaz Named to Women's Health List of 125 Best Packaged Foods for Women 2Health News:Study Links Serum Calcium, Prostate Cancer Death 2Health News:Study Links Serum Calcium, Prostate Cancer Death 3Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 2Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 3Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 4Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 5
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 1Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 2Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 3Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 4Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 5Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 6Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 7Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 8Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 9Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 10Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 11Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 12Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 13MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 6597 1MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 6597 2eHealthSource com Launches Online Shopping Site Dedicated to Over the Counter Medications Approved for FSA HSA Claims 6590 1eHealthSource com Launches Online Shopping Site Dedicated to Over the Counter Medications Approved for FSA HSA Claims 6590 2
...N, South Korea, Jan. 12 Jennerex,Inc. (San Franci... partner,Green Cross Corp., today announced treatm...y liver cancer clinical trial using its targeted a...s were reported, and enrollment of,patients onto t...volves treatment of patients with advanced, primar...
...Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a ... and development of drugs for the treatment of hum...unced that it has initiated a proof-of-concept stu...candidate for the treatment of HCV under an Invest... Food and Drug Administration (FDA). The study is ...
Other Medicine Technology:Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 2Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 3Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 4Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 2Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 3Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 4
Creatine Kinase (CK-NAC)
Alanine Aminotransferase (ALT) GPT
Alkaline Phosphatase (ALP) (DIMENSION)
...ost other EMR,systems require you to,change th...c patient charting,solution designed to fit into...round,five specific criteria to,enhance overal...oPad allows you to see,more patients in the same...
Medicine Products: